Strongest Appetite Suppressant Over the Counter Now Available in USA - PhenQ Medically Accredited Craving Control Supplement OTC
Phenq
New York City, NY, June 30, 2025 (GLOBE NEWSWIRE) -- For Americans seeking the most effective, safe, and convenient way to control food cravings and promote weight loss, a breakthrough is here.
PhenQ, the strongest appetite suppressant over the counter (OTC), has officially launched in the United States and worldwide—earning the rare and coveted 'clinicians' choice' status after being medically accredited by over 800 medical professionals.
For men and women looking to lose weight, manage appetite, and improve overall health without the risks of prescription appetite suppressants or weight loss drugs, PhenQ is the OTC appetite suppressant the world has been waiting for.
Product Launch: A New Era for Clinician-Backed OTC Appetite Suppressants
PhenQ's arrival marks a turning point in the world of weight loss supplements. For decades, Americans have struggled to find effective appetite suppressant pills that are both safe and available without a prescription.
Prescription appetite suppressants and weight loss drugs often require doctor supervision, can lead to high blood pressure, and may not be suitable for those with a higher body mass index or specific health concerns.
Now, with PhenQ, users can experience the best appetite suppressant over the counter, with a formula that has been medically accredited, approved, and recommended by over 800 clinicians.
This level of medical endorsement is a rarity for OTC appetite suppressants, making PhenQ the clear leader in the category.
Main PhenQ Benefits & Features
PhenQ delivers a multi-faceted approach to weight loss and appetite control. Here's what makes it the most effective appetite suppressant OTC and a top choice for weight management:
1. Clinically Proven Appetite Suppressant
PhenQ's formula contains α-Lacys Reset®, a patented complex that accelerates metabolism and promotes thermogenesis, helping users suppress appetite and burn calories more efficiently. Clinical studies have shown that people using α-Lacys Reset® lost up to 7.24% of body fat, 3.44% of body weight, and gained 3.8% muscle mass, making it a unique weight loss supplement for those looking to lose weight while retaining lean muscle.
2. Reduces Food Cravings
Through its blend of chromium picolinate, nopal cactus, and natural caffeine, PhenQ helps reduce cravings for sweets and carbs. This powerful appetite suppressant formula is designed to help users stay on track, avoid emotional eating, and break the cycle of late-night snacking.
3. Promotes Weight Loss and Fat Burning
PhenQ combines thermogenic agents like Capsimax powder (a blend of capsicum, piperine, caffeine, and niacin) to ignite fat burning and help users reach their weight loss goals faster. This is not just an appetite suppressant, but a comprehensive weight loss supplement for total body transformation.
4. Enhances Energy and Mood
Unlike many diet pills or prescription appetite suppressants that can cause fatigue or mood swings, PhenQ contains caffeine, nopal, and L-carnitine to provide all-day energy and cognitive support. This keeps users motivated, focused, and ready to conquer their health and fitness journey.
5. Supports Normal Appetite and Keto Lifestyles
PhenQ is a natural appetite suppressant that fits perfectly into keto or low-carb diets, helping users manage appetite and maintain healthy eating habits for sustainable weight loss.
6. No Prescription Required—100% OTC
As one of the strongest OTC appetite suppressants, PhenQ is available for purchase without a prescription. This makes appetite control more accessible than ever for millions of Americans.
7. Vegan & Vegetarian Friendly
PhenQ is made from 100% vegan and vegetarian ingredients, ensuring inclusivity for a wide variety of dietary needs.
Company Name and Location
PhenQ (USA)Wolfson Brands (UK) Limited12 Payne Street, Glasgow, G4 0LF, United KingdomDistributed in the USA, Canada, UK, Australia and globally
PhenQ Pricing Details
PhenQ is competitively priced with attractive savings for multi-bottle purchases and includes a risk-free guarantee:
1 Bottle: $69.99 (Retail $79.99) — 1 Month Supply
2 Bottles + 1 Free: $139.99 (Retail $239.99) — 3 Month Supply (Most Popular)
3 Bottles + 2 Free: $209.99 (Retail $399.99) — 5 Month Supply (Best Value)
Free Shipping: On all orders over $79.99
60-Day Money-Back Guarantee: Try it risk-free
Order and see current offers at official PhenQ website
Launch Date & Availability
PhenQ is now available to buy OTC in the United States and ships to over 190 countries. Orders are processed and shipped within 24–48 hours from warehouses in the US, UK, and Germany. PhenQ is also now available for purchase worldwide, providing rapid delivery and discreet packaging.
Scientific Data and Studies
PhenQ's appetite suppressant formula is backed by clinical research:
α-Lacys Reset®: Clinical trials published in peer-reviewed journals demonstrate significant reductions in body weight, body fat, and increased muscle mass compared to placebo.
Capsimax Powder: Research in Bioscience Report highlights the ability of capsaicinoids to increase thermogenesis and potentially stop the formation of new fat cells.
Chromium Picolinate: An eight-week Cornell University study showed chromium supplementation helps reduce carb cravings and supports healthy blood sugar levels.
Caffeine: Multiple studies confirm caffeine's ability to suppress appetite, increase alertness, and boost metabolic rate.
Nopal Cactus: Rich in fiber and amino acids, nopal helps manage appetite, increase satiety, and reduce fluid retention.
References:
Whiting S, Derbyshire E, Tiwari BK. (2012) Appetite Control.
Zemel MB, Thompson W, Milstead A, et al. (2004) Obesity Research.
Docherty JP, Sack DA, et al. (2005) Journal of Psychiatry Practice.
Health & Safety Benefits
PhenQ is designed as a safe, effective alternative to prescription appetite suppressants and weight loss drugs:
All-Natural Appetite Suppressant: PhenQ includes only natural, high-grade ingredients with a strong safety record.
No Major Side Effects: No prescription required, and hundreds of thousands of users have reported no significant adverse effects.
Suitable for Long-Term Use: Can be used as long as needed for weight management, unlike some weight loss drugs that are only approved for short-term use.
No Habit-Forming Ingredients: Unlike some prescription appetite suppressants, PhenQ is non-addictive and safe for ongoing use.
Made in FDA & GMP Approved Facilities: All manufacturing is done under strict quality controls in the US and UK.
Scientific Innovation of OTC Weight Loss Supplements
What makes PhenQ a leader among OTC appetite suppressants and diet pills?
Multi-Action Formula: Combines the strongest ingredients for appetite control, fat burning, energy, and mood—unlike most other weight loss supplements that target a single aspect.
α-Lacys Reset®: A unique, trademarked, and scientifically validated ingredient at the heart of PhenQ's effectiveness.
Synergy of Ingredients: Each component supports the others for a holistic approach to appetite suppression and weight management.
Transparency: Full ingredient disclosure and clinical research citations—no hidden blends or proprietary secrets.
OTC Diet Pills Market Disruption
PhenQ is fundamentally disrupting the appetite suppressant and weight loss supplement industry:
Medically Studied by 800 Professionals: PhenQ's 'clinicians' choice' status is nearly impossible to attain and sets a new bar for OTC appetite suppressant pills.
Outperforms Prescription Appetite Suppressants: Without the need for a prescription or risk of high blood pressure and other side effects, PhenQ is safer and more accessible.
Superior to Traditional Diet Pills: PhenQ's multi-pronged formula makes it more effective than many single-purpose appetite suppressant pills or dietary supplements.
No Prescription, No Hassle: PhenQ brings prescription-level results to the OTC market—no waiting rooms, no doctor's approval necessary.
Consumer Benefits
Users of PhenQ enjoy a wide range of benefits—making it the strongest and most trusted OTC appetite suppressant available:
Strongest Appetite Suppressant OTC: Clinically proven to suppress appetite, crush cravings, and help users lose weight effectively.
Promotes Weight Loss: Helps reduce calorie intake, supports fat burning, and assists in lowering body weight and body mass index.
Appetite Control and Satiety: Natural ingredients help users feel full, satisfied, and in control of their eating habits.
Counter Appetite and Emotional Eating: Reduces stress-related snacking and helps break the cycle of emotional eating.
Supports Healthy Weight Management: Sustained use assists in long-term maintenance of healthy weight, reducing the risk of regaining lost pounds.
Safe for Most Adults: No major side effects, no habit-forming components, and suitable for both men and women.
Fits Modern Lifestyles: Only two pills per day, no drastic diet changes required, and works with keto and other popular diets.
Money-Back Guarantee: If you're not satisfied, get a full refund within 60 days—no questions asked.
Quote from PhenQ Spokesperson
'PhenQ is the result of years of scientific research and clinical study. To be named a clinicians' choice by over 800 medical professionals is an extraordinary honor—and a testament to our commitment to safety, effectiveness, and transparency. As the strongest OTC appetite suppressant available today, PhenQ is helping people in the USA and around the world take control of their appetite, lose weight safely, and achieve lasting health.'— Kay Norris, Product Innovation, PhenQ
Distribution Channels
Direct-to-Consumer: Only available from the official site to guarantee authenticity and best pricing.
Worldwide Shipping: To over 190 countries, with free shipping on orders over $79.99.
Discreet Packaging: All orders shipped in plain packaging for your privacy.
Website URL & Contact Person Details
Website: https://phenq.com/pages/appetite-suppressant
Email: support@phenq.com
Phone: +1 (646) 513 2632
For media inquiries:Wolfson Brands (UK) Limited12 Payne Street, Glasgow, G4 0LF, United Kingdomsupport@phenq.com
Safety Certifications & Testing
FDA & GMP Approved Facilities: Manufactured to the highest US and UK standards.
Third-Party Lab Testing: For purity, potency, and safety.
Full Ingredient Transparency: No hidden blends or undisclosed substances.
Vegan & Vegetarian Safe: 100% plant-based ingredients.
Product Usage & Dosage
Recommended Use: Take one PhenQ pill with breakfast and one with lunch.
Do Not Exceed Recommended Dose: Due to natural caffeine content, avoid taking after 3pm.
Long-Term Use: Safe for ongoing appetite control and weight management.
Appetite Suppressants in the Modern Age: How PhenQ Changes the Game
Appetite suppressants work by helping users feel full, reduce food cravings, and lower overall calorie intake. However, most prescription appetite suppressants and weight loss drugs come with potential side effects, high blood pressure risks, and often require strict medical supervision. OTC appetite suppressants like PhenQ are changing this landscape by providing a safe, effective, and accessible solution for Americans struggling with weight management.
PhenQ's unique composition of scientifically proven ingredients sets it apart from alli weight loss pill and other common dietary supplements. It is not just a diet pill; it is a comprehensive, medically endorsed appetite suppressant designed to suppress cravings, promote weight loss, and support lasting health.
Conclusion: The Future of Appetite Control Is Here
PhenQ is the strongest appetite suppressant over the counter now available in the USA and worldwide—backed by 800 medical professionals and trusted by nearly 200,000 satisfied customers. With its powerful, natural appetite suppressant formula, robust clinical validation, and unmatched safety profile, PhenQ is setting a new standard for OTC appetite suppressants and weight management.
About PhenQ (USA) / Wolfson BrandsPhenQ is produced by Wolfson Brands, a global leader in health innovation. With a focus on science, safety, and customer success, PhenQ continues to redefine what's possible in appetite suppressant pills and weight loss supplements.
Media Contact:Kay Norris, Head of Product InnovationWolfson Brands (UK) Limited12 Payne Street, Glasgow, G4 0LF, United Kingdomsupport@phenq.com
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a physician before use.Attachment
Phenq
CONTACT: For media inquiries: Website: https://phenq.com/pages/appetite-suppressant Email: support@phenq.com Phone: +1 (646) 513 2632 Wolfson Brands (UK) Limited 12 Payne Street, Glasgow, G4 0LF, United Kingdom support@phenq.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
an hour ago
- Boston Globe
From Ozempic envy to ghosting friends: How GLP-1s are reshaping relationships
It's been two and a half years since host Jimmy Kimmel's Get Love Letters: The Newsletter A weekly dispatch with all the best relationship content and commentary – plus exclusive content for fans of Love Letters, Dinner With Cupid, weddings, therapy talk, and more. Enter Email Sign Up Some of the people who most need the drugs for health reasons still can't get them because of affordability issues, a situation that is creating disparities along racial and socioeconomic lines, as the Advertisement But in whiter and wealthier circles, the drugs have filtered down to seemingly everyone: neighbors, colleagues, the cousin who's always been competitive with you. Almost 12 percent of Americans have used GLP-1 drugs for weight loss, and an additional 14 percent say they're interested, according to a recent Advertisement As they become an ever-larger presence in a twisted society that still largely equates thinness with virtue and beauty, the drugs are no longer just reshaping bodies. They're changing relationships. Jealousy, secrecy, and lies are rippling through friendships, marriages, and even doctors' appointments. 'If I get my GLP1 through an online clinic, will they tell my primary care doctor?' asked a 'I KNOW this is not ideal,' the user acknowledged, 'but I also take … [Adderall] and I don't want him … to stop prescribing my meds….' In South Boston, Mary, 35, who asked her last name not be used, is already stressing about her doctor's appointment. It's in December. As a child she was sent to 'fat camp,' and has grown into a binge eater who thinks about food constantly. But because she's overweight but not obese, she fears her doctor doesn't understand the depth of her struggle. This summer, almost certain the doctor wouldn't write her a prescription, she took matters into her own hands and got an online prescription for She's lost about 25 pounds, but she's worried about telling her doctor. 'I'm not going to lie to her,' she said, 'but I've got myself into a pickle.' In many ways, the drugs are putting many people in a no-win situation. Some people are being judged for taking them. Others for not taking them. Advertisement 'People have this idea that being fat makes you horrible, and losing the fat any way other than 'their' way also makes you horrible,' said Jacqui Conforti, 47, a manager in a high-tech company. 'It's an addiction, pure and simple, and if someone offered drug addicts or alcoholics a pill to cure their addiction, the creators would receive a Nobel prize. But because this is helping fat people, it is demonized.' Jen Gaouette, 35, who said she's about 100 pounds overweight, faces the opposite problem. 'Why aren't you on Ozempic?' strangers demand. Lingering problems from a car accident make her particularly concerned about 'I don't like people implying that I need to be fixed,' she said, 'or assuming that I'm not already working on what they see as a problem.' A dosage of Wegovy. Amanda Andrade-Rhoades/Associated Press The new drugs are triggering emotions that many wish they didn't have. In a Boston suburb, a wife who is struggling to lose weight for lack of a GLP-1 prescription finds herself being happy for — but also sort of resenting — her husband, who's dropping pounds easily on a weight-loss drug. 'I get up early to exercise while he's in bed or watching the news,' she said. 'It gets frustrating. I'm cutting my portions in half, and he wants to go out for ice cream.' Meanwhile, Amanda Torrey, 48, a nanny and a She'd like to lose 25 to 50 pounds, but instead has been gaining weight. Recently, she saw one of her many friends who is taking a GLP-1. The friend was 100 pounds thinner than she'd been, and looked 'adorable,' Torrey said. 'And she was feeling great.' Advertisement Torrey couldn't get the transformation out of her mind. 'Maybe I should just do it,' she told her partner. He'd like to lose weight, too, but they reminded each other about the side effects and how they don't want to start a drug they'd be on for life, or put themselves at the 'whim' of an insurance company. So that was that. Or was it? 'Everyone else looks so good,' she said wistfully. Beth Teitell can be reached at
Business Wire
an hour ago
- Business Wire
LEO Pharma Delivers 7% Revenue Growth at CER in H1 2025 and Achieves Key Milestones Enabling Future Growth
BALLERUP, Denmark--(BUSINESS WIRE)--In H1 2025, LEO Pharma delivered robust growth and significantly improved profitability, enabling an increase to the financial outlook for sales growth and adjusted EBITDA margin in 2025 towards the upper-end of previously communicated expectations. In July, the FDA approval of Anzupgo® and partnership with Boehringer Ingelheim for SPEVIGO®, marked major strategic milestones demonstrating LEO Pharma's commitment to advancing innovation in dermatology. Highlights LEO Pharma's revenue increased by 6% year-on-year to DKK 6,789 million, and by 7% at constant exchange rates (CER) entirely driven by organic growth. The revenue growth was led by North America (+28% at CER), with Europe (+1% at CER) and Rest of World (+4% at CER) also contributing to the overall growth. Revenue from the Dermatology portfolio grew by 8% (CER) year-on-year, driven by the Strategic brands Adtralza ® /Adbry ® and Anzupgo ®, which combined had a revenue increase of 51% (CER). Sales in the Critical Care portfolio (formerly called 'Thrombosis') declined by 3% (CER) year-on-year, affected by the reversal of sales discounts in the same period last year. Operating profit improved significantly, with adjusted EBITDA reaching DKK 1,456 million in H1 2025, reflecting a margin of 21% (H1 2024: 9%) excluding the STAT6 partnership upfront payment from Gilead received in January and other non-recurring items. Net profit for H1 2025 was DKK 1,977 million (H1 2024: negative DKK 761 million), including non-recurring items. Free cash flow was DKK 1,469 million for H1 2025 (H1 2024: negative DKK 779 million), and net interest-bearing debt was reduced to DKK 9,676 million (YE 2024: DKK 11,115 million). Excluding M&A, free cash flow was negative DKK 158 million driven by timing and non-recurring one-offs. On 23 July, LEO Pharma received FDA approval of Anzupgo® (delgocitinib) for the treatment of chronic hand eczema, enabling launch of the product in the U.S. by Q3 2025 as the first and only topical pan-JAK inhibitor. Additionally, LEO Pharma on 9 July announced positive interim results from the phase 3 ADHAND trial for Adtralza®/Adbry® (tralokinumab). On 14 July, LEO Pharma announced a partnership with Boehringer Ingelheim, granting LEO Pharma an exclusive global license for the development and commercialization of SPEVIGO® (spesolimab), a first-in-class IL-36R antagonist already approved and marketed for generalized pustular psoriasis (GPP). The partnership aims to accelerate and broaden access for patients by leveraging LEO Pharma's global dermatology platform. The transaction is expected to close in H2 2025 with SPEVIGO® set to become the third Strategic brand in LEO Pharma's portfolio, alongside Adtralza®/Adbry® and Anzupgo®. For the 2025 outlook, group revenue growth is now expected to be 7-9% at CER (previously: 6-9%) and the adjusted EBITDA margin is now expected to be 16-18% (previously: 15-18%). This reflects the FDA approval of Anzupgo® and year-to-date business performance. The outlook does not include any impact from the partnership for SPEVIGO®, pending closing of the transaction. LEO Pharma is in its strongest position in years – financially, strategically, and in terms of our portfolio and pipeline activities. The FDA approval of Anzupgo® represents a major step forward, and together with the addition of SPEVIGO® to our portfolio, we are further unlocking the value of our global platform, highlighting our commitment to driving innovation for patients.' CEO Christophe Bourdon. About LEO Pharma LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people's lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually. Head-quartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, visit
New York Post
an hour ago
- New York Post
This hidden heart condition is known as a ‘silent killer' — how to know if you need treatment, even with no symptoms
Time for a heart-to-heart. Cardiovascular disease is the leading cause of death in the US, killing more Americans than cancer and unintentional injuries — including car crashes, falls and overdoses — combined. You've probably heard of heart attacks, strokes and heart failure, but there's a lesser-known, dangerous condition that's often referred to as a 'silent killer.' Advertisement An aortic aneurysm is a bulge of the aorta, the body's largest blood vessel, which carries oxygenated blood from the heart to the rest of the body. Here are key risk factors for aortic aneurysms and the latest treatment options. Inside the aorta The aorta begins at the heart's base within the left ventricle, then extends upward, forming the aortic arch, before descending through the chest and into the belly. Broadly speaking, there are two main types of aortic aneurysms. Advertisement Thoracic aneurysms generally refer to aneurysms in the chest, while abdominal aneurysms involve the part of the aorta that runs through the belly. 3 Consider getting screened if you have a family history of aortic aneurysms or if you're a man over 65 who has smoked cigarettes. volha_r – The most common type of aortic aneurysm is the infrarenal, which occurs in the abdominal aorta below the kidneys. The size of aneurysms varies depending on their location in the body. Advertisement For example, in the chest, an aneurysm is when the aortic diameter is greater than 4.5 centimeters. In the belly, a diameter of over 3 centimeters qualifies as an aneurysm. What causes aortic aneurysms? While the exact cause of aneurysms is often unknown, there are risk factors associated with the likelihood of developing one. Age, the male sex, genetics and a bicuspid aortic valve — a common congenital heart defect where the aortic valve has two cusps instead of three — are important factors for aneurysms in the chest. Advertisement A bicuspid aortic valve occurs in about 1% of the population. 3 Dr. Geraldine Ong is a clinical associate professor in the Department of Medicine, the Leon H. Charney Division of Cardiology at NYU Langone Health and medical director of NYU Langone's Aortic Center. Mateo Salcedo For aneurysms in the abdomen, age and being male are major factors, as well as high blood pressure and smoking. You can reduce your risk with lifestyle changes such as quitting smoking, controlling blood pressure, following a heart-healthy diet and exercising regularly — though you should avoid very heavy lifting. Consider getting screened if you have a family history of aortic aneurysms or if you're a man over 65 who has smoked cigarettes. Patients referred to our Aortic Center receive an evaluation and a personalized care plan, including genetic testing, advanced imaging and lifestyle recommendations. How aortic aneurysms are diagnosed People often ask us, 'What are the symptoms of an aortic aneurysm?' And the truth is, the majority of patients don't have symptoms. Aortic aneurysms are considered 'silent killers' because most patients don't know they have them. Advertisement Fortunately, thanks to modern medical imaging techniques, most patients receive treatment before symptoms occur. 3 Ong works alongside Dr. Mark Peterson, professor in the Department of Cardiothoracic Surgery, who also serves as system director of aortic surgery for NYU Langone Heart. Mateo Salcedo Many patients are referred to our Aortic Center after a test they had done for another reason, such as a cough that didn't go away, palpitations or a murmur, which led to an echocardiogram or a CT scan that uncovered the aneurysm. When symptoms do occur, they can signal something major, like the aorta is about to rupture or a tear has developed, a serious condition known as an aortic dissection. Advertisement If you suddenly experience the worst chest pain of your life, a stabbing sensation radiating from front to back or severe abdominal pain, don't hesitate to call 911. The sooner you get to the hospital for treatment, the better. We understand that a diagnosis of an aneurysm can be very anxiety-provoking. The good news is that our multidisciplinary team of experts is here every step of the way, from imaging to lifestyle changes and advice on blood pressure management to surgery if that's required — and often it's not. Our patients live full and active lives. How aortic aneurysms are treated Many patients with aortic aneurysms don't need immediate surgery. Aneurysm size and location are significant factors in determining when surgery is necessary. Advertisement There are two main ways to treat aortic aneurysms. One is open aortic surgery, where a cut is made to directly access the aorta. Due to the location of aortic root and ascending aortic aneurysm and the desire to preserve the aortic valve, we tend to use open surgical techniques more often to repair aneurysms closer to the heart. The other involves accessing the femoral artery in the groin. We insert a stent graft, which is basically like relining the inside of the aorta. Technological advances mean more people can receive stent grafts instead of open surgery. It's generally minimally invasive. Sometimes it's even done when patients are awake. And it helps patients get out of the hospital faster. Most of our surgical patients are in and out of the hospital within three to four days. They're able to return to their daily routine — and hopefully live very long and happy lives. Advertisement Dr. Geraldine Ong, clinical associate professor in the Department of Medicine, the Leon H. Charney Division of Cardiology at NYU Langone Health and medical director of NYU Langone's Aortic Center, works alongside Dr. Mark Peterson, professor in the Department of Cardiothoracic Surgery, who also serves as system director of aortic surgery for NYU Langone Heart. Together, they lead the Aortic Center, bringing together expertise on the diagnosis and treatment of complex aortic conditions. US News & World Report's 'Best Hospitals' ranks NYU Langone No.1 hospital in the US for cardiology, heart and vascular surgery.
